Zhu H, Doğan BE. American Joint Committee on Cancer’s Staging System for Breast Cancer, eighth ed. Summary for clinicians. Eur J Breast Heal. 2021;17(3):234. https://doi.org/10.4274/EJBH.GALENOS.2021.2021-4-3

National Comprehensive Cancer Network. Breast cancer (version 1.2024). https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf2.2019). Accessed February 27, 2024.

Veronesi U, Arnone P, Veronesi P, et al. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol. 2008;19(9):1553-60. https://doi.org/10.1093/annonc/mdn183

Jeong CJ, Bae JM, Park SY, Han BK, Ko ES, Ko EY. Metastatic internal mammary lymph nodes or mimickers on parasternal ultrasonography: focusing on their distribution and depth. Acta Radiol. 2018;59(1):34–40. https://doi.org/10.1177/0284185117702180.

Article  PubMed  Google Scholar 

Veronesi U, Cascinelli N, Bufalino R, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg. 1983;198(6):681–4. https://doi.org/10.1097/00000658-198312000-00002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi X wei, Du J ze, Tang P, et al. Clinical significance of internal mammary lymph node metastasis for breast cancer: Analysis of 337 breast cancer patients. Surg Oncol. 2018;27(2):185-91. https://doi.org/10.1016/J.SURONC.2018.03.006

Cong B Bin, Cao XS, Cao L, et al. Internal mammary lymph nodes radiotherapy of breast cancer in the era of individualized medicine. Oncotarget. 2017;8(46):81583-81590. https://doi.org/10.18632/ONCOTARGET.20186

Caudle AS, Yi M, Hoffman KE, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA, Hunt KK. Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients. Ann Surg Oncol. 2014;21(1):60–5. https://doi.org/10.1245/s10434-013-3276-z. (Epub 2013 Sep 18 PMID: 24046126).

Article  PubMed  Google Scholar 

Kim J, Chang JS, Choi SH, et al. Radiotherapy for initial clinically positive internal mammary nodes in breast cancer. Radiat Oncol J. 2019;37(2):91. https://doi.org/10.3857/ROJ.2018.00451.

Article  PubMed  PubMed Central  Google Scholar 

Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer. 1999;35(9):1320-5. https://doi.org/10.1016/S0959-8049(99)00133-1

Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C. Radical mastectomy versus radical mastectomy plus internal mammary dissection ten year results of an international cooperative trial in breast cancer. Cancer. 1983;51:1941–3. https://doi.org/10.1002/1097-0142.

Article  CAS  PubMed  Google Scholar 

Poortmans P, Collette S, Struikmans H, et al. Fifteen-year results of the randomised EORTC trial 22922/10925 investigating internal mammary and medial supraclavicular (IM-MS) lymph node irradiation in stage I-III breast cancer. 2018; https://doi.org/10.1200/JCO.2018.36.15_SUPPL.504

McGale P, Taylor C, Correa C, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet (London, Engl). 2014;383(9935):2127–35. https://doi.org/10.1016/S0140-6736(14)60488-8.

Article  CAS  Google Scholar 

Thorsen LBJ, Offersen BV, Danø H, et al. DBCG-IMN: A population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol. 2016;34(4):314–20. https://doi.org/10.1200/JCO.2015.63.6456.

Article  PubMed  Google Scholar 

Yang K, Kim H, Choi DH, Park W, Noh JM, Cho WK. Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer. Radiat Oncol. 2020;15(1):1–12. https://doi.org/10.1186/S13014-020-1464-0/TABLES/9.

Article  Google Scholar 

Morrow M, Foster RS. Staging of breast cancer: a new rationale for internal mammary node biopsy. Arch Surg. 1981;116(6):748–51. https://doi.org/10.1001/ARCHSURG.1981.01380180012003.

Article  CAS  PubMed  Google Scholar 

Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR. Internal mammary nodes in breast cancer: diagnosis and implications for patient management—a systematic review. J Clin Oncol. 2008;26(30):4981–9. https://doi.org/10.1200/JCO.2008.17.4862.

Article  PubMed  Google Scholar 

Harlow S, Krag D, Weaver D, Ashikaga T. Extra-axillary sentinel lymph nodes in breast cancer. Breast Cancer. 1999;6(2):159–65. https://doi.org/10.1007/BF02966925.

Article  CAS  PubMed  Google Scholar 

Andring LM, Diao K, Sun S, et al. Locoregional management and prognostic factors in breast cancer with ipsilateral internal mammary and axillary lymph node involvement. Int J Radiat Oncol Biol Phys. 2022;113(3):552–60. https://doi.org/10.1016/J.IJROBP.2022.02.037.

Article  PubMed  Google Scholar 

Kim H, Kim SS, Lee IJ, et al. Outcome of radiotherapy for clinically overt metastasis to the internal mammary lymph node in patients receiving neoadjuvant chemotherapy and breast cancer surgery. Breast. 2021;55:112–8. https://doi.org/10.1016/J.BREAST.2020.12.011.

Article  PubMed  Google Scholar 

Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599–609. https://doi.org/10.1093/JNCI/DJJ158.

Article  PubMed  Google Scholar 

Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657–63. https://doi.org/10.1200/JCO.2006.07.4062.

Article  PubMed  Google Scholar 

Che Bakri NA, Kwasnicki RM, Khan N, et al. Impact of axillary lymph node dissection and sentinel lymph node biopsy on upper limb morbidity in breast cancer patients: a systemiatic review and meta-analysis. Ann Surg. 2023;277(4):572–80. https://doi.org/10.1097/SLA.0000000000005671.

Article  PubMed  Google Scholar 

Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609–18. https://doi.org/10.1016/S1470-2045(13)70166-9.

Article  PubMed  Google Scholar 

Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455–61. https://doi.org/10.1001/JAMA.2013.278932.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33(3):258–63. https://doi.org/10.1200/JCO.2014.55.7827.

Article  PubMed  Google Scholar 

Boughey JC, Ballman KV, Le-Petross HT, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0–T4, N1–N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance). Ann Surg. 2016;263(4):802–7. https://doi.org/10.1097/SLA.0000000000001375.

Article  PubMed  Google Scholar 

Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072–8. https://doi.org/10.1200/JCO.2015.64.0094.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallagher KK, Iles K, Kuzmiak C, Louie R, McGuire KP, Ollila DW. Prospective evaluation of radar-localized reflector-directed targeted axillary dissection in node-positive breast cancer patients after neoadjuvant systemic therapy. J Am Coll Surg. 2022;234(4):538–45. https://doi.org/10.1097/XCS.0000000000000098.

Article  PubMed  Google Scholar 

Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261(2):378–82. https://doi.org/10.1097/SLA.0000000000000558.

Article  PubMed  Google Scholar 

Guo X, Zhang J, Gong X, et al. Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: is it necessary? Breast. 2024;73. https://doi.org/10.1016/J.BREAST.2024.103671

Beniey M, Boulva K, Rodriguez-Qizilbash S, Kaviani A, Younan R, Patocskai E. Targeted axillary dissection in node-positive breast cancer: a retrospective study and cost analysis. Cureus. 2021;13(4). https://doi.org/10.7759/CUREUS.14610

Ai X, Liao X, Li J, Tang P, Jiang J. Clinical outcomes of N3 breast cancer: a real-world study of a single institution and the US Surveillance, Epidemiology, and End Results (SEER) Database. Cancer Manag Res. 2020;12:5331. https://doi.org/10.2147/CMAR.S246162.

Article  PubMed  PubMed Central  Google Scholar 

Andring LM, Diao K, Sun SX, et al. Prognostic factors in breast cancer patients with clinical n3b (ipsilateral internal mammary and axillary) disease. Int J Radiat Oncol. 2021;111(3):e195–6. https://doi.org/10.1016/J.IJROBP.2021.07.706.

Article  Google Scholar 

Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: A powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683. https://doi.org/10.1245/S10434-007-9747-3.

Article  PubMed  PubMed Central